Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18443353 | PERSONAL CARE COMPOSITION COMPRISING WATER INSOLUBLE SOLID ORGANIC COMPOUND | February 2024 | September 2024 | Allow | 7 | 0 | 0 | Yes | No |
| 18231455 | MITOCHONDRIAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN AND HAIR | August 2023 | January 2025 | Abandon | 18 | 1 | 0 | No | No |
| 18217298 | COSMETIC OIL THICKENER AND OIL-SOLUBLE COPOLYMER | June 2023 | March 2025 | Allow | 21 | 1 | 1 | Yes | No |
| 18316360 | SILK FIBROIN BIOCOMPATIBLE POLYURETHANE MEMBRANES | May 2023 | April 2025 | Allow | 23 | 2 | 1 | Yes | No |
| 18165311 | METHOD OF USING A STYE TREATMENT FORMULATION TO TREAT AT LEAST ONE STYE, AT LEAST ONE CHALAZION, BLEPHARITIS, OR ANY COMBINATION THEREOF | February 2023 | August 2024 | Abandon | 18 | 1 | 0 | No | No |
| 18078902 | BIOLOGICALLY MODIFIED VASCULAR GRAFTS FOR IMPROVED BYPASS SURGERY OUTCOMES | December 2022 | October 2024 | Abandon | 22 | 1 | 1 | No | No |
| 17993604 | EMULSIFYING COMPOSITION FOR COSMETIC USE FOR PRODUCING AN O/W PICKERING EMULSION AND PROCESS FOR PRODUCING THIS EMULSION | November 2022 | March 2025 | Abandon | 28 | 2 | 1 | No | No |
| 17965628 | HIGH-POTENCY VITAMIN C AND SUGAR ALCOHOL TOPICAL FORMULATIONS | October 2022 | March 2024 | Allow | 18 | 2 | 1 | Yes | No |
| 17934813 | Particles for Targeted Delivery and Uses in Managing Bleeding or Blood Clotting | September 2022 | March 2023 | Allow | 6 | 0 | 0 | No | No |
| 17759666 | EXTERNAL SKIN PREPARATION | July 2022 | June 2025 | Allow | 35 | 2 | 0 | Yes | No |
| 17873515 | Method of Thickening Cosmetic Composition | July 2022 | April 2024 | Abandon | 21 | 2 | 1 | No | No |
| 17808978 | COMPOSITIONS AND METHODS FOR WOUND TREATMENT | June 2022 | March 2024 | Allow | 21 | 1 | 1 | Yes | No |
| 17752671 | COSMETIC COMPOSITIONS IN PARTICULAR WITH ANTI-AGING EFFECT, COMPRISING A GREEN EXTRACT OF AFRAMOMUM ANGUSTIFOLIUM OR LONGOZA PLANT | May 2022 | August 2024 | Abandon | 27 | 4 | 0 | Yes | No |
| 17658707 | ORAL BACLOFEN SOLUTIONS | April 2022 | July 2024 | Abandon | 27 | 3 | 0 | No | No |
| 17658255 | STYE TREATMENT FORMULATION AND METHODS OF USE THEREOF | April 2022 | May 2023 | Abandon | 14 | 2 | 0 | Yes | No |
| 17713717 | ORALLY ADMINISTRABLE FORMULATIONS FOR THE CONTROLLED RELEASE OF A PHARMACOLOGICALLY ACTIVE AGENT | April 2022 | April 2024 | Abandon | 24 | 1 | 1 | No | No |
| 17623810 | ORAL CARE GUMMIES | December 2021 | April 2025 | Abandon | 39 | 0 | 1 | No | No |
| 17561631 | CIPROFLOXACIN OPHTHALMIC TOPICAL COMPOSITION FOR TREATING OCULAR DISEASE | December 2021 | March 2023 | Allow | 15 | 2 | 0 | No | No |
| 17619464 | EXTENDED-RELEASE SOLID ORAL DOSAGE FORM COMPRISING VITAMIN B12 AND A VITAMIN B12 DEPLETING DRUG | December 2021 | February 2025 | Abandon | 38 | 0 | 1 | No | No |
| 17545409 | SYNERGISTIC ANTIBACTERIAL ACTIVITY OF MEDIUM POLARITY OILS IN COMBINATION WITH ANTIBACTERIAL AGENTS ON BACTERIAL BIOFILMS | December 2021 | January 2023 | Allow | 13 | 1 | 0 | No | No |
| 17611999 | LIGHT-CURING COMPOSITIONS FOR TREATING ONYCHOMYCOSIS (FUNGAL NAIL INFECTION) | November 2021 | February 2025 | Abandon | 39 | 0 | 1 | No | No |
| 17453095 | VITAMIN D BASE LAYER | November 2021 | April 2025 | Allow | 41 | 5 | 0 | Yes | No |
| 17512251 | SYSTEM, METHOD, AND COMPOSITION FOR SKIN IMPROVEMENT AND TRANSIENT FLORA REDUCTION | October 2021 | May 2025 | Allow | 42 | 3 | 1 | Yes | No |
| 17498881 | TOPICAL BARRIER COMPOSITION FOR DERMAL APPLICATION | October 2021 | November 2023 | Abandon | 25 | 1 | 1 | No | No |
| 17442822 | SUNSCREEN COSMETIC | September 2021 | July 2022 | Allow | 10 | 1 | 1 | Yes | No |
| 17593732 | USE OF DIANHYDROHEXITOL FOR PRESERVING COSMETIC PREPARATIONS | September 2021 | March 2024 | Abandon | 30 | 1 | 1 | No | No |
| 17447785 | 4-in-1 Facial and Body Wipe | September 2021 | June 2024 | Abandon | 33 | 1 | 0 | No | No |
| 17436555 | PROCESS FOR THE PREPARATION OF HAIR TREATMENT COMPOSITIONS CONTAINING ORGANIC C1-C6 ALKOXY SILANES | September 2021 | May 2025 | Abandon | 44 | 0 | 1 | No | No |
| 17444958 | SKINCARE PRODUCT AND MULTI-DIMENSIONAL ASCORBIC ACID SERUM FORMULATION THEREFOR | August 2021 | October 2023 | Abandon | 26 | 1 | 1 | No | No |
| 17428309 | FATTY ACID ESTERS AS ANTI-MALASSEZIA AGENTS | August 2021 | January 2025 | Allow | 41 | 2 | 1 | Yes | No |
| 17386641 | COMPOSITION COMPRISING AT LEAST ONE GLYCOSYLATED FLAVONOID AND ITS USE IN COSMETICS OR DERMATOLOGY | July 2021 | January 2024 | Abandon | 30 | 1 | 1 | No | No |
| 17386142 | TRANSFER-RESISTANT TOPCOAT COMPOSITION | July 2021 | January 2025 | Abandon | 41 | 5 | 0 | Yes | No |
| 17375065 | SHINE ENHANCING SPRAY COMPOSITION | July 2021 | November 2024 | Abandon | 40 | 4 | 1 | No | No |
| 17422492 | SURFACTANT COMPOSITION | July 2021 | May 2025 | Allow | 47 | 2 | 1 | Yes | No |
| 17367220 | METHODS TO IDENTIFY AND TREAT CISPLATIN-RESISTANT OVARIAN CANCER | July 2021 | October 2024 | Abandon | 39 | 0 | 1 | No | No |
| 17360415 | COSMETIC COMPOSITION PROVIDING UNIQUE SENSATIONS | June 2021 | June 2025 | Allow | 48 | 4 | 0 | Yes | Yes |
| 17418158 | SOLID HAIR CONDITIONING COMPOSITION | June 2021 | September 2024 | Abandon | 39 | 0 | 1 | No | No |
| 17354345 | PREPARATION OF A PHARMACEUTICAL COMPOSITION OF OLODATEROL, TIOTROPIUM BROMIDE AND BUDESONIDE | June 2021 | December 2022 | Abandon | 17 | 2 | 1 | No | No |
| 17416145 | COSMETIC COMPOSITION FOR KERATIN FIBERS COMPRISING C14-20 FATTY ACID AND SEMICRYSTALLINE POLYMER | June 2021 | December 2023 | Abandon | 30 | 1 | 1 | No | No |
| 17416245 | ANHYDROUS COSMETIC COMPOSITION COMPRISING A LIQUID FATTY SUBSTANCE, A SOLID FATTY SUBSTANCE AND A SURFACTANT | June 2021 | January 2025 | Abandon | 43 | 0 | 1 | No | No |
| 17415547 | GENT FOR DYEING HAIR, CONTAINING AT LEAST ONE ORGANIC SILICON COMPOUND I | June 2021 | November 2024 | Abandon | 41 | 0 | 1 | No | No |
| 17311954 | MICROEMULSION COMPOSITION, CURED MATERIAL THEREOF, AND COSMETIC CONTAINING THE CURED MATERIAL | June 2021 | June 2024 | Abandon | 36 | 2 | 1 | No | No |
| 17295030 | BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE | May 2021 | May 2025 | Abandon | 48 | 2 | 1 | No | No |
| 17294170 | COSMETIC COMPOSITION FOR IMPROVING FRAGRANCE PERSISTENCE | May 2021 | June 2025 | Allow | 49 | 2 | 0 | Yes | No |
| 17315630 | COSMETIC COMPOSITION IN THE FORM OF A REVITALIZING AND TONING OIL-IN-WATER EMULSION FOR SKIN AND LIPS | May 2021 | March 2023 | Abandon | 23 | 0 | 1 | No | No |
| 17289468 | CROSSLINKED MATERIALS | April 2021 | April 2025 | Allow | 47 | 1 | 1 | Yes | No |
| 17225481 | Nano-Emulsion Cosmetic Composition In Which High Content Oils Are Stabilized | April 2021 | June 2024 | Abandon | 38 | 3 | 0 | Yes | No |
| 17225634 | Manufacturing of Semi-Plastic Pharmaceutical Dosage Units | April 2021 | October 2023 | Allow | 30 | 1 | 1 | No | No |
| 17281718 | ANGIOGENESIS PROMOTER AND THERAPEUTIC METHOD | March 2021 | August 2024 | Allow | 40 | 1 | 1 | Yes | No |
| 17218945 | METHODS AND COMPOSITIONS FOR IMPROVING SKIN | March 2021 | June 2024 | Allow | 39 | 2 | 1 | Yes | No |
| 17277924 | METHOD FOR PRODUCING GLYCERYL ETHER-CONTAINING COMPOSITION, AND GLYCERYL ETHER-CONTAINING COMPOSITION | March 2021 | January 2024 | Allow | 34 | 3 | 1 | No | No |
| 17187084 | GEL STABILIZED O/W EMULSION WITH ALPHA-ARBUTIN AND AZELAIC ACID DISPERSION | February 2021 | September 2024 | Allow | 42 | 4 | 0 | No | Yes |
| 17268398 | SELF-HEALING OR SELF-REPAIRING FILM FORMING COMPOSITION | February 2021 | July 2023 | Allow | 29 | 2 | 0 | Yes | No |
| 17259982 | A PROCESS FOR MAKING PERSONAL CARE FORMULATION | January 2021 | December 2023 | Abandon | 35 | 3 | 0 | No | No |
| 17143215 | Hair and Scalp Treatment Solution | January 2021 | October 2022 | Abandon | 22 | 1 | 0 | No | No |
| 17141615 | FRESHNESS-RETENTIVE FILM | January 2021 | August 2024 | Abandon | 43 | 3 | 0 | No | No |
| 17140755 | DRY POWDER VANCOMYCIN COMPOSITIONS AND ASSOCIATED METHODS | January 2021 | November 2022 | Abandon | 23 | 0 | 1 | No | No |
| 17139048 | COMPOSITION COMPRISING AT LEAST TWO FATTY ACID ESTERS OF (POLY)GLYCEROL, AND USE THEREOF IN COSMETICS | December 2020 | November 2022 | Abandon | 23 | 3 | 0 | No | No |
| 17126369 | TRANSPARENT COMPOSITION WITH SOLUBLE SCALP HEALTH ACTIVE | December 2020 | August 2023 | Allow | 32 | 2 | 0 | No | No |
| 17253400 | EMULSION COMPRISING A SILICONE RESIN, A LIQUID POLYOL AND PIGMENTS, PREPARATION OF THE EMULSION, AND PROCESS USING SAME | December 2020 | January 2025 | Abandon | 49 | 4 | 1 | No | No |
| 15734851 | SURFACTANT FOR WATER-IN-OIL EMULSION | December 2020 | January 2023 | Allow | 26 | 1 | 1 | Yes | No |
| 17104241 | Treatment of Rhinitis | November 2020 | October 2022 | Abandon | 23 | 0 | 1 | No | No |
| 17056514 | PRESERVATION COMPOSITIONS | November 2020 | December 2022 | Allow | 25 | 2 | 1 | Yes | No |
| 17052729 | COSMETIC OIL THICKENER AND OIL-SOLUBLE COPOLYMER | November 2020 | December 2023 | Abandon | 37 | 1 | 1 | Yes | No |
| 17085496 | PHASE CHANGE COSMETIC COMPOSITION | October 2020 | January 2024 | Allow | 39 | 4 | 1 | No | No |
| 17076388 | PRESSURE-SENSITIVE HYDROGEL AND METHOD OF USE | October 2020 | October 2022 | Abandon | 24 | 1 | 1 | Yes | No |
| 17048393 | POWDEROUS FORMULATION | October 2020 | May 2024 | Abandon | 43 | 3 | 1 | No | No |
| 17047798 | ABSORBENT PRODUCTS WITH ANTI-BACTERIAL AND ANTI-ODOUR PROPERTIES | October 2020 | July 2024 | Abandon | 45 | 0 | 1 | No | No |
| 17047587 | EMULSIFYING COMPOSITION FOR COSMETIC USE FOR PRODUCING AN O/W PICKERING EMULSION AND PROCESS FOR PRODUCING THIS EMULSION | October 2020 | August 2023 | Allow | 34 | 2 | 1 | No | No |
| 17066476 | METHODS FOR COSMETIC SKIN REMODELING | October 2020 | April 2025 | Abandon | 54 | 4 | 1 | Yes | No |
| 17037180 | DERIVATIVES OF MENTHOL AND USES THEREOF | September 2020 | November 2022 | Allow | 26 | 2 | 1 | Yes | No |
| 17042916 | TOPICAL PREPARATION CONTAINING VITAMIN K1 AND PREPARATION METHOD THEREOF | September 2020 | October 2021 | Allow | 12 | 2 | 1 | Yes | No |
| 17024592 | Compositions and Methods for Wound Treatment | September 2020 | February 2022 | Allow | 17 | 2 | 0 | No | No |
| 16338691 | Gynecological vaginal wash for adjusting female vaginal microecology and preparation method thereof | September 2020 | March 2024 | Abandon | 60 | 1 | 1 | Yes | No |
| 16968826 | COMPOSITION COMPRISING OPTICAL CLEARING AGENT FOR IMPROVING OPTICAL CHARACTERISTIC OF SKIN | August 2020 | January 2023 | Abandon | 29 | 2 | 1 | No | No |
| 16947423 | METHODS FOR PROTECTING HAIR FOLLICLES | July 2020 | April 2023 | Abandon | 33 | 2 | 1 | No | Yes |
| 16927442 | FORTIFIED PLANT-BASED FORMULATIONS | July 2020 | June 2023 | Abandon | 35 | 2 | 0 | No | No |
| 16916496 | COSMETIC COMPOSITIONS HAVING STABILIZED RETINOL | June 2020 | August 2023 | Allow | 38 | 3 | 1 | Yes | No |
| 16911598 | SPRAY-DRIED PHARMACEUTICAL COMPOSITIONS COMPRISING ACTIVE AGENT NANOPARTICLES | June 2020 | October 2020 | Allow | 4 | 0 | 0 | Yes | No |
| 16957434 | COMPOSITION FOR CONDITIONING KERATIN FIBERS | June 2020 | January 2024 | Allow | 42 | 6 | 1 | No | No |
| 16955614 | DECORATIVE AQUEOUS COMPOSITION AND METHOD FOR PRODUCING SAME | June 2020 | January 2023 | Abandon | 31 | 2 | 1 | Yes | No |
| 16955003 | HAIR TREATMENT PROCESS USING A FLAVIN DERIVATIVE AND LIGHT RADIATION | June 2020 | March 2023 | Abandon | 33 | 3 | 1 | Yes | No |
| 16954504 | COSMETIC | June 2020 | December 2022 | Abandon | 30 | 2 | 1 | No | No |
| 16894258 | USE OF VANILLIN DERIVATIVES AS A PRESERVATIVE, PRESERVATION METHOD, COMPOUNDS, AND COMPOSITION | June 2020 | January 2022 | Allow | 19 | 2 | 0 | Yes | No |
| 16892423 | LOTEPREDNOL ETABONATE NANOPARTICLES IN THERMOREVERSIBLE GELS FOR ENHANCED THERAPEUTICS | June 2020 | February 2021 | Allow | 8 | 1 | 0 | No | No |
| 16769410 | APPLICATIONS OF AN ESTER ADDITIVE FROM BIODERIVED RAW MATERIALS | June 2020 | January 2025 | Abandon | 55 | 2 | 1 | No | No |
| 16767930 | COSMETIC COMPOSITION FOR IMPROVING SKIN CONDITION COMPRISING MIXTURE OF BRASSICA OLERACEA VAR. ACEPHALA SEAWATER EXTRACT, NASTURTIUM OFFICINALE SEAWATER EXTRACT AND BETA VULGARIS ROOT SEAWATER EXTRACT | May 2020 | February 2023 | Abandon | 33 | 3 | 1 | No | No |
| 16765533 | METHODS FOR PREPARING CURCUMINOID COMPOSITIONS | May 2020 | March 2022 | Allow | 22 | 2 | 1 | Yes | No |
| 16765428 | THICKENED ONE-COMPONENT HAIR TONER | May 2020 | January 2023 | Abandon | 32 | 2 | 1 | Yes | No |
| 16764754 | COSMETIC COMPOSITIONS IN PARTICULAR WITH ANTI-AGING EFFECT, COMPRISING A GREEN EXTRACT OF AFRAMOMUM ANGUSTIFOLIUM OR LONGOZA PLANT | May 2020 | November 2022 | Abandon | 30 | 2 | 1 | No | No |
| 15931561 | INDUCTION OF A PHYSIOLOGICAL DISPERSION RESPONSE IN BACTERIAL CELLS IN A BIOFILM | May 2020 | April 2022 | Allow | 23 | 1 | 1 | Yes | No |
| 16868199 | CRACKING AEROSOL COMPOSITION | May 2020 | July 2023 | Abandon | 38 | 3 | 1 | Yes | No |
| 16848814 | Drug Delivery Devices and Methods of Making and Using Same | April 2020 | February 2024 | Abandon | 46 | 4 | 1 | Yes | No |
| 16755730 | METHOD OF USE OF PERSONAL CLEANSING COMPOSITIONS | April 2020 | February 2023 | Abandon | 34 | 1 | 0 | No | No |
| 16844136 | Abuse-deterrent pharmaceutical compositions | April 2020 | July 2021 | Abandon | 15 | 1 | 1 | No | No |
| 16753593 | HAIRSTYLING COMPOSITION | April 2020 | January 2024 | Allow | 45 | 4 | 1 | Yes | Yes |
| 16652469 | INVERSE EMULSION THICKENERS | March 2020 | October 2021 | Allow | 19 | 0 | 1 | Yes | No |
| 16651878 | ANTIOXIDIZING, ANTIAGING, OR ANTI-INFLAMMATORY COMPOSITION FOR STRENGTHENING SKIN BARRIER AND CARING FOR SKIN CELL DAMAGE CAUSED BY FINE DUST INCLUDING FERMENTED TEA EXTRACT | March 2020 | June 2025 | Abandon | 60 | 6 | 1 | Yes | No |
| 16649398 | OIL-IN-WATER EMULSION COSMETIC USING ULTRAMICROEMULSION | March 2020 | August 2022 | Abandon | 28 | 1 | 1 | No | No |
| 16648334 | UREA GROUP-CONTAINING ORGANOPOLYSILOXANE, METHOD FOR MANUFACTURING UREA GROUP-CONTAINING ORGANOPOLYSILOXANE, AND COSMETIC | March 2020 | June 2022 | Abandon | 27 | 2 | 1 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BERRIOS, JENNIFER A.
With a 20.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 22.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner BERRIOS, JENNIFER A works in Art Unit 1613 and has examined 853 patent applications in our dataset. With an allowance rate of 39.7%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 35 months.
Examiner BERRIOS, JENNIFER A's allowance rate of 39.7% places them in the 4% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by BERRIOS, JENNIFER A receive 2.43 office actions before reaching final disposition. This places the examiner in the 83% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by BERRIOS, JENNIFER A is 35 months. This places the examiner in the 19% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +54.6% benefit to allowance rate for applications examined by BERRIOS, JENNIFER A. This interview benefit is in the 96% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 15.0% of applications are subsequently allowed. This success rate is in the 6% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 15.1% of cases where such amendments are filed. This entry rate is in the 10% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 50.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 40% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 61.0% of appeals filed. This is in the 33% percentile among all examiners. Of these withdrawals, 55.3% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 64.5% are granted (fully or in part). This grant rate is in the 81% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 1.2% of allowed cases (in the 70% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 0% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.